Dasatinib Overrides Imatinib Resistance Mediated by the F359I Residue Mutation in Two Patients with Chronic Myeloid Leukemia.
Acta haematologica（2011）
关键词
BCR-ABL kinase,Chronic myelogenous leukemia,F359I point mutation,Kinase inhibitors,Suboptimal response
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要